Xinyu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLINDAMYCIN PHOSPHATE USP, with a corresponding US DMF Number 24358.
Remarkably, this DMF maintains an Active status since its submission on November 08, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2025, and payment made on November 12, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II